VIOLIN Logo
VO Banner
Search: for Help
About
Introduction
Statistics
VIOLIN News
Your VIOLIN
Register or Login
Submission
Tutorial
Vaccine & Components
Vaxquery
Vaxgen
VBLAST
Protegen
Virmugen
Vaxjo
Vaxvec
Vaccine Mechanisms
Vaxism
Vaxar
Vaccine Literature
Litesearch
Vaxpresso
Vaxmesh
Vaxlert
Vaccine Design
Vaxign
Community Efforts
Vaccine Ontology
Advisory Committee
Vaccine Society
Vaxperts
VaxPub
VaxCom
VaxLaw
VaxMedia
VaxMeet
VaxFund
VaxCareer
VIOLIN Wiki
Data Exchange
V-Utilities
VIOLINML
Help & Documents
Documents
FAQs
Links
Acknowledgements
Disclaimer
Contact Us
UMMS Logo

Vaxlert: Peer-reviewed Vaccine Publications in Current Month

From Jul 01, 2010 To Jul 30, 2010:


Bacillus anthracis (Anthrax)

  1. Soliakov A, Harris JR, Watkinson A, Lakey JH. The structure of Yersinia pestis Caf1 polymer in free and adjuvant bound states Vaccine 28(35):5746-5754 2010 [PMID: 20600492]
  2. Radjainia M, Hyun JK, Leysath CE, Leppla SH, Mitra AK. Anthrax toxin-neutralizing antibody reconfigures the protective antigen heptamer into a supercomplex Proceedings of the National Academy of Sciences of the United States of America 2010 [PMID: 20660775]
  3. . Use of Anthrax Vaccine in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009 MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control 59(RR-6):1-30 2010 [PMID: 20651644]
  4. Twenhafel NA. Pathology of Inhalational Anthrax Animal Models Veterinary pathology 2010 [PMID: 20656900]
  5. Michell S, Dean RE, Eyles JE, Hartley MG, Waters E, Prior JL, Titball RW, Oyston PC. Deletion of the Bacillus anthracis capB homologue in Francisella tularensis subspecies tularensis generates an attenuated strain that protects mice against virulent tularemia Journal of medical microbiology 2010 [PMID: 20651039]
  6. Langley WA, Li ZN, Bradley KC, Talekar GR, Galloway SE, Steinhauer DA. The effects of preexisting immunity to influenza on responses to influenza vectors in mice Vaccine 2010 [PMID: 20656032]
  7. Brady RA, Verma A, Meade BD, Burns DL. Analysis of Antibody Responses to Protective Antigen-Based Anthrax Vaccines through Use of Competitive Assays Clinical and vaccine immunology : CVI 2010 [PMID: 20631338]
  8. Ramirez K, Ditamo Y, Galen JE, Baillie LW, Pasetti MF. Mucosal priming of newborn mice with S. Typhi Ty21a expressing anthrax protective antigen (PA) followed by parenteral PA-boost induces B and T cell-mediated immunity that protects against infection bypassing maternal antibodies Vaccine 2010 [PMID: 20619377]
  9. Scarlata F, Colletti P, Bonura S, Trizzino M, Giordano S, Titone L. [The return of anthrax. From bioterrorism to the zoonotic cluster of Sciacca district.] Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive 18(2):86-90 2010 [PMID: 20610930]

Brucella (Brucellosis)

  1. Commander NJ, Brewer JM, Wren BW, Spencer SA, Macmillan AP, Stack JA. Liposomal delivery of p-ialB and p-omp25 DNA vaccines improves immunogenicity but fails to provide full protection against B. melitensis challenge Genetic vaccines and therapy 8(1):5 2010 [PMID: 20637091]
  2. Eoh H, Jeon BY, Kim Z, Kim SC, Cho SN. Expression and validation of d-erythrulose 1-phosphate dehydrogenase from Brucella abortus: a diagnostic reagent for bovine brucellosis Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc 22(4):524-530 2010 [PMID: 20622221]
  3. Surendran N, Hiltbold EM, Heid B, Sriranganathan N, Boyle SM, Zimmerman KL, Makris MR, Witonsky SG. Live Brucella abortus rough vaccine strain RB51 stimulates enhanced innate immune response in vitro compared to rough vaccine strain RB51SOD and virulent smooth strain 2308 in murine bone marrow-derived dendritic cells Veterinary microbiology 2010 [PMID: 20594772]

Clostridium botulinum toxin (Botulism)

  1. Sanford D, Barnewall RE, Vassar ML, Niemuth N, Metcalfe K, House RV, Henderson I, Shearer JD. Inhalational Botulism in Rhesus Macaques Exposed to Botulinum Neurotoxin Complex Serotypes A1 and B1 Clinical and vaccine immunology : CVI 2010 [PMID: 20660138]
  2. Clapp B, Golden S, Maddaloni M, Staats HF, Pascual DW. Adenovirus F protein as a delivery vehicle for botulinum B BMC immunology 11(1):36 2010 [PMID: 20609248]

Clostridium perfringens

  1. Lanckriet A, Timbermont L, Eeckhaut V, Haesebrouck F, Ducatelle R, Van Immerseel F. Variable protection after vaccination of broiler chickens against necrotic enteritis using supernatants of different Clostridium perfringens strains Vaccine 2010 [PMID: 20600504]
  2. Clark S, Porter R, McComb B, Lipper R, Olson S, Nohner S, Shivaprasad HL. Clostridial dermatitis and cellulitis: an emerging disease of turkeys Avian diseases 54(2):788-794 2010 [PMID: 20608520]

Coxiella burnetii (Q fever)

  1. Sukocheva OA, Marmion BP, Storm PA, Lockhart M, Turra M, Graves S. Long-term persistence after acute Q fever of non-infective Coxiella burnetii cell components, including antigens QJM : monthly journal of the Association of Physicians 2010 [PMID: 20639288]
  2. Burnett D, Burnett L. A rare granulomatous reaction to Q fever vaccination following influenza vaccination The Medical journal of Australia 193(1):60 2010 [PMID: 20618120]

Ebola virus

  1. Geisbert TW, Bausch DG, Feldmann H. Prospects for immunisation against Marburg and Ebola viruses Reviews in medical virology 2010 [PMID: 20658513]

Escherichia coli

  1. Roche JK, Cabel A, Sevilleja J, Nataro J, Guerrant RL. Enteroaggregative Escherichia coli (EAEC) Impairs Growth while Malnutrition Worsens EAEC Infection: A Novel Murine Model of the Infection Malnutrition Cycle The Journal of infectious diseases 202(4):506-514 2010 [PMID: 20594107]
  2. Aguilar-Yáñez JM, Portillo-Lara R, Mendoza-Ochoa GI, García-Echauri SA, López-Pacheco F, Bulnes-Abundis D, Salgado-Gallegos J, Lara-Mayorga IM, Webb-Vargas Y, León-Angel FO, Rivero-Aranda RE, Oropeza-Almazán Y, Ruiz-Palacios GM, Zertuche-Guerra MI, Dubois RM, White SW, Schultz-Cherry S, Russell CJ, Alvarez MM. An Influenza A/H1N1/2009 Hemagglutinin Vaccine Produced in Escherichia coli PloS one 5(7):e11694 2010 [PMID: 20661476]
  3. Bommakanti G, Citron MP, Hepler RW, Callahan C, Heidecker GJ, Najar TA, Lu X, Joyce JG, Shiver JW, Casimiro DR, Ter Meulen J, Liang X, Varadarajan R. Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challenge Proceedings of the National Academy of Sciences of the United States of America 2010 [PMID: 20615991]
  4. Yin S, Sun S, Yang S, Shang Y, Cai X, Liu X. Self-assembly of virus-like particles of porcine circovirus type 2 capsid protein from Escherichia coli Virology journal 7(1):166 2010 [PMID: 20646322]
  5. Nielubowicz GR, Mobley HL. Host-pathogen interactions in urinary tract infection Nature reviews. Urology 2010 [PMID: 20647992]
  6. Sommer U, Petersen J, Pfeiffer M, Schrotz-King P, Morsczeck C. Comparison of surface proteomes of enterotoxigenic (ETEC) and commensal Escherichia coli strains Journal of microbiological methods 2010 [PMID: 20643167]
  7. Laguia-Becher M, Martin V, Kraemer M, Corigliano M, Yacono ML, Goldman A, Clemente M. Effect of codon optimization and subcellular targeting on Toxoplasma gondii antigen SAG1 expression in tobacco leaves to use in subcutaneous and oral immunization in mice BMC biotechnology 10(1):52 2010 [PMID: 20633272]
  8. Rivera FP, Ochoa TJ, Maves RC, Bernal M, Medina AM, Meza R, Barletta F, Mercado E, Ecker L, Gil AI, Hall ER, Huicho L, Lanata CF. Genotypic and phenotypic characterization of enterotoxigenic Escherichia coli (ETEC) strains isolated from Peruvian children Journal of clinical microbiology 2010 [PMID: 20631096]
  9. Khare S, Alali W, Zhang S, Hunter D, Pugh R, Fang FC, Libby SJ, Adams LG. Vaccination with attenuated Salmonella enterica Dublin expressing E. coli O157:H7 outer membrane protein Intimin induces transient reduction of fecal shedding of E. coli O157:H7 in cattle BMC veterinary research 6(1):35 2010 [PMID: 20609252]
  10. Parizi LF, Utiumi KU, Imamura S, Onuma M, Ohashi K, Masuda A, da Silva Vaz I Jr. Cross immunity with Haemaphysalis longicornis glutathione S-transferase reduces an experimental Rhipicephalus (Boophilus) microplus infestation Experimental parasitology 2010 [PMID: 20619263]
  11. Hong Y, Han H, Peng J, Li Y, Shi Y, Fu Z, Liu J, Lin J, Li X. Schistosoma japonicum: Cloning, expression and characterization of a gene encoding the alpha5-subunit of the proteasome Experimental parasitology 2010 [PMID: 20599988]
  12. He S, Yang L, Lv Z, Hu W, Cao J, Wei J, Sun X, Yang J, Zheng H, Wu Z. Molecular and functional characterization of a mortalin-like protein from Schistosoma japonicum (SjMLP/hsp70) as a member of the HSP70 family Parasitology research 2010 [PMID: 20602114]
  13. Bhuvanesh S, Arunkumar C, Kaliraj P, Ramalingam S. Production and single-step purification of Brugia malayi abundant larval transcript (ALT-2) using hydrophobic interaction chromatography Journal of industrial microbiology & biotechnology 2010 [PMID: 20593300]
  14. Cohen D, Tobias J, Spungin-Bialik A, Sela T, Kayouf R, Volovik Y, Yavzori M, Ephros M. Phenotypic Characteristics of Enterotoxigenic Escherichia coli Associated with Acute Diarrhea Among Israeli Young Adults Foodborne pathogens and disease 2010 [PMID: 20590426]
  15. Devriendt B, Stuyven E, Verdonck F, Goddeeris BM, Cox E. Enterotoxigenic Escherichia coli (K88) induce proinflammatory responses in porcine intestinal epithelial cells Developmental and comparative immunology 2010 [PMID: 20600278]
  16. Ooka H, Terkawi MA, Goo YK, Luo Y, Li Y, Yamagishi J, Nishikawa Y, Igarashi I, Xuan X. Babesia microti: Molecular and antigenic characterizations of a novel 94-kDa protein (BmP94) Experimental parasitology 2010 [PMID: 20599995]
  17. Clark S, Porter R, McComb B, Lipper R, Olson S, Nohner S, Shivaprasad HL. Clostridial dermatitis and cellulitis: an emerging disease of turkeys Avian diseases 54(2):788-794 2010 [PMID: 20608520]
  18. Subbarayan P, Qin H, Pillai S, Lee JJ, Pfendt AP, Willing G, Miller ME, Dennis VA, Singh SR. Expression and characterization of a multivalent human respiratory syncytial virus protein Molekuliarnaia biologiia 44(3):477-487 2010 [PMID: 20608172]

Francisella tularensis (Tularemia)

  1. Michell S, Dean RE, Eyles JE, Hartley MG, Waters E, Prior JL, Titball RW, Oyston PC. Deletion of the Bacillus anthracis capB homologue in Francisella tularensis subspecies tularensis generates an attenuated strain that protects mice against virulent tularemia Journal of medical microbiology 2010 [PMID: 20651039]
  2. Jia Q, Lee BY, Bowen R, Dillon BJ, Som SM, Horwitz MA. A Francisella tularensis Live Vaccine Strain mutant with a deletion in capB, encoding a putative capsular biosynthesis protein, is significantly more attenuated than LVS yet induces potent protective immunity in mice against F. tularensis challenge Infection and immunity 2010 [PMID: 20643859]
  3. Duplantis BN, Osusky M, Schmerk CL, Ross DR, Bosio CM, Nano FE. Essential genes from Arctic bacteria used to construct stable, temperature-sensitive bacterial vaccines Proceedings of the National Academy of Sciences of the United States of America 2010 [PMID: 20624965]
  4. Bina XR, Miller MA, Bina JE. Construction of a bioluminescence reporter plasmid for Francisella tularensis Plasmid 2010 [PMID: 20620161]
  5. Apicella MA, Post DM, Fowler AC, Jones BD, Rasmussen JA, Hunt JR, Imagawa S, Choudhury B, Inzana TJ, Maier TM, Frank DW, Zahrt TC, Chaloner K, Jennings MP, McLendon MK, Gibson BW. Identification, characterization and immunogenicity of an O-antigen capsular polysaccharide of Francisella tularensis PloS one 5(7):e11060 2010 [PMID: 20625403]
  6. Paranavitana C, Zelazowska E, DaSilva L, Pittman PR, Nikolich M. Th17 cytokines in recall responses against Francisella tularensis in humans Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 30(7):471-476 2010 [PMID: 20626289]
  7. Huntley JF, Robertson GT, Norgard MV. Method for the isolation of Francisella tularensis outer membranes Journal of visualized experiments : JoVE (40) 2010 [PMID: 20613713]
  8. Mokrievich AN, Kondakova AN, Valade E, Platonov ME, Vakhrameeva GM, Shaikhutdinova RZ, Mironova RI, Blaha D, Bakhteeva IV, Titareva GM, Kravchenko TB, Kombarova TI, Vidal D, Pavlov VM, Lindner B, Dyatlov IA, Knirel YA. Biological properties and structure of the lipopolysaccharide of a vaccine strain of Francisella tularensis generated by inactivation of a quorum sensing system gene qseC Biochemistry. Biokhimiia 75(4):443-451 2010 [PMID: 20618133]

Human immunodeficiency virus (acquired immunodeficiency syndrome)

  1. Mendes-Correa MC, Pinho JR, Locarnini S, Yuen L, Sitnik R, Santana RA, Gomes-Gouvêa MS, Leite OM, Martins LG, Silva MH, Gianini RJ, Uip DE. High frequency of lamivudine resistance mutations in Brazilian patients co-infected with HIV and hepatitis B Journal of medical virology 82(9):1481-1488 2010 [PMID: 20648600]
  2. Shang L, Hunter E. Residues in the membrane-spanning domain core modulate conformation and fusogenicity of the HIV-1 envelope glycoprotein Virology 404(2):158-167 2010 [PMID: 20605619]
  3. Kanazawa T, Takashima Y, Tamura T, Tsuchiya M, Shibata Y, Udagawa H, Okada H. Local gene expression and immune responses of vaginal DNA vaccination using a needle-free injector International journal of pharmaceutics 396(1-2):11-16 2010 [PMID: 20621704]
  4. Gilbert P, Wang M, Wrin T, Petropoulos C, Gurwith M, Sinangil F, D'Souza P, Rodriguez-Chavez IR, Decamp A, Giganti M, Berman PW, Self SG, Montefiori DC. Magnitude and Breadth of a Nonprotective Neutralizing Antibody Response in an Efficacy Trial of a Candidate HIV-1 gp120 Vaccine The Journal of infectious diseases 202(4):595-605 2010 [PMID: 20608874]
  5. Franco D, Li W, Qing F, Stoyanov CT, Moran T, Rice CM, Ho DD. Evaluation of yellow fever virus 17D strain as a new vector for HIV-1 vaccine development Vaccine 28(35):5676-5685 2010 [PMID: 20600494]
  6. Overton ET, Kang M, Peters MG, Umbleja T, Alston-Smith BL, Bastow B, Demarco-Shaw D, Koziel MJ, Mong-Kryspin L, Sprenger HL, Yu JY, Aberg JA. Immune response to hepatitis B vaccine in HIV-infected subjects using granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant: ACTG study 5220 Vaccine 28(34):5597-5604 2010 [PMID: 20600512]
  7. Hervouet C, Luci C, Cuburu N, Cremel M, Bekri S, Vimeux L, Marañon C, Czerkinsky C, Hosmalin A, Anjuère F. Sublingual immunization with an HIV subunit vaccine induces antibodies and cytotoxic T cells in the mouse female genital tract Vaccine 28(34):5582-5590 2010 [PMID: 20600505]
  8. Taylor PR, Koski GK, Paustian CC, Bailey E, Cohen PA, Moore FB, Zimmerman DH, Rosenthal KS. J-LEAPS vaccines initiate murine Th1 responses by activating dendritic cells Vaccine 28(34):5533-5542 2010 [PMID: 20600501]
  9. Liang B, Luo M, Ball TB, Jones SJ, Plummer FA. QUASI analysis of host immune responses to Gag polyproteins of human immunodeficiency virus type 1 by a systematic bioinformatics approach Biochemistry and cell biology = Biochimie et biologie cellulaire 88(4):671-681 2010 [PMID: 20651839]
  10. Yu M, Vajdy M. Mucosal HIV transmission and vaccination strategies through oral compared with vaginal and rectal routes Expert opinion on biological therapy 10(8):1181-1195 2010 [PMID: 20624114]
  11. Barratt-Boyes SM, Wijewardana V, Brown KN. In acute pathogenic SIV infection plasmacytoid dendritic cells are depleted from blood and lymph nodes despite mobilization Journal of medical primatology 39(4):235-242 2010 [PMID: 20618589]
  12. Shen H, Wang C, Yang E, Xu Y, Liu W, Yan J, Wang F, Wang H. Novel recombinant BCG coexpressing Ag85B, ESAT-6 and mouse TNF-alpha induces significantly enhanced cellular immune and antibody responses in C57BL/6 mice Microbiology and immunology 54(8):435-441 2010 [PMID: 20646207]
  13. Wahren B, Biswas P, Borggren M, Coleman A, Da Costa K, De Haes W, Dieltjens T, Dispinseri S, Grupping K, Hallengard D, Hornig J, Klein K, Mainetti L, Palma P, Reudelsterz M, Seifried J, Selhorst P, Skold A, van Gils MJ, Weber C, Shattock R, Scarlatti G. Rational design of HIV vaccine and microbicides: report of the EUROPRISE annual conference Journal of translational medicine 8(1):72 2010 [PMID: 20659333]
  14. Peeters M, Fobang Aghokeng A, Delaporte E. Genetic diversity among HIV-1 non-B subtypes in viral load and drug resistance assays Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2010 [PMID: 20649800]
  15. Lewis DA. The Gonococcus fights back: is this time a knock out? Sexually transmitted infections 2010 [PMID: 20656721]
  16. Lauring AS, Andino R. Quasispecies theory and the behavior of RNA viruses PLoS pathogens 6(7):e1001005 2010 [PMID: 20661479]
  17. Luque AE, Hitti J, Mwachari C, Lane C, Messing S, Cohn SE, Adler D, Rose R, Coombs R. Prevalence of human papillomavirus genotypes in HIV-1-infected women in Seattle, USA and Nairobi, Kenya: results from the Women's HIV Interdisciplinary Network (WHIN) International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2010 [PMID: 20655263]
  18. Kong L, Huang CC, Coales SJ, Molnar KS, Skinner J, Hamuro Y, Kwong PD. Local conformational stability of HIV-1 gp120 in unliganded and CD4-bound states as defined by amide hydrogen/deuterium exchange Journal of virology 2010 [PMID: 20660185]
  19. Folkers GK, Fauci AS. Controlling and ultimately ending the HIV/AIDS pandemic: a feasible goal JAMA : the journal of the American Medical Association 304(3):350-351 2010 [PMID: 20639573]
  20. Cooper CJ, Metch B, Dragavon J, Coombs RW, Baden LR. Vaccine-induced HIV seropositivity/reactivity in noninfected HIV vaccine recipients JAMA : the journal of the American Medical Association 304(3):275-283 2010 [PMID: 20639561]
  21. Scurlock D. A piece of my mind. Vaccine, please JAMA : the journal of the American Medical Association 304(3):250-251 2010 [PMID: 20639552]
  22. Verhagen LM, Warris A, van Soolingen D, de Groot R, Hermans PW. Human Immunodeficiency Virus and Tuberculosis Coinfection in Children: Challenges in Diagnosis and Treatment The Pediatric infectious disease journal 2010 [PMID: 20651637]
  23. Siddappa NB, Watkins JD, Wassermann KJ, Song R, Wang W, Kramer VG, Lakhashe S, Santosuosso M, Poznansky MC, Novembre FJ, Villinger F, Else JG, Montefiori DC, Rasmussen RA, Ruprecht RM. R5 Clade C SHIV Strains with Tier 1 or 2 Neutralization Sensitivity: Tools to Dissect Env Evolution and to Develop AIDS Vaccines in Primate Models PloS one 5(7):e11689 2010 [PMID: 20657739]
  24. Aliyu G, Mohammad M, Saidu A, Mondal P, Charurat M, Abimiku A, Nasidi A, Blattner W. HIV infection awareness and willingness to participate in future HIV vaccine trials across different risk groups in Abuja, Nigeria AIDS care :1-8 2010 [PMID: 20661789]
  25. Chakrabarti LA, Simon V. Immune mechanisms of HIV control Current opinion in immunology 2010 [PMID: 20650621]
  26. Subramanya S, Armant M, Salkowitz JR, Nyakeriga AM, Haridas V, Hasan M, Bansal A, Goepfert PA, Wynn KK, Ladell K, Price DA, N M, Kan-Mitchell J, Shankar P. Enhanced Induction of HIV-specific Cytotoxic T Lymphocytes by Dendritic Cell-targeted Delivery of SOCS-1 siRNA Molecular therapy : the journal of the American Society of Gene Therapy 2010 [PMID: 20648001]
  27. Sugimoto C, Watanabe S, Naruse T, Kajiwara E, Shiino T, Umano N, Ueda K, Sato H, Ohgimoto S, Hirsch V, Villinger F, Ansari AA, Kimura A, Miyazawa M, Suzuki Y, Yamamoto N, Nagai Y, Mori K. Protection of Macaques with Diverse MHC Genotypes against a Heterologous SIV by Vaccination with a Deglycosylated Live-Attenuated SIV PloS one 5(7):e11678 2010 [PMID: 20652030]
  28. Li X, Fujio M, Imamura M, Wu D, Vasan S, Wong CH, Ho DD, Tsuji M. Design of a potent CD1d-binding NKT cell ligand as a vaccine adjuvant Proceedings of the National Academy of Sciences of the United States of America 107(29):13010-13015 2010 [PMID: 20616071]
  29. Traina-Dorge V, Pahar B, Marx P, Kissinger P, Montefiori D, Ou Y, Gray WL. Recombinant varicella vaccines induce neutralizing antibodies and cellular immune responses to SIV and reduce viral loads in immunized rhesus macaques Vaccine 2010 [PMID: 20654666]
  30. Sremac M, Stuart ES. SIVsm Tat, Rev, and Nef1: functional characteristics of r-GV internalization on isotypes, cytokines, and intracellular degradation BMC biotechnology 10(1):54 2010 [PMID: 20642814]
  31. Benmira S, Bhattacharya V, Schmid ML. An Effective HIV Vaccine: A Combination of Humoral and Cellular Immunity? Current HIV research 2010 [PMID: 20636279]
  32. Pistone T, Verdière CH, Receveur MC, Ezzedine K, Lafon ME, Malvy D. Immunogenicity and Tolerability of Yellow Fever Vaccination in 23 French HIV-Infected Patients Current HIV research 2010 [PMID: 20636276]
  33. Doores KJ, Bonomelli C, Harvey DJ, Vasiljevic S, Dwek RA, Burton DR, Crispin M, Scanlan CN. Envelope glycans of immunodeficiency virions are almost entirely oligomannose antigens Proceedings of the National Academy of Sciences of the United States of America 2010 [PMID: 20643940]
  34. Newman PA, Logie C. HIV vaccine acceptability: a systematic review and meta-analysis AIDS (London, England) 24(11):1749-1756 2010 [PMID: 20597165]
  35. Naruse TK, Chen Z, Yanagida R, Yamashita T, Saito Y, Mori K, Akari H, Yasutomi Y, Miyazawa M, Matano T, Kimura A. Diversity of MHC class I genes in Burmese-origin rhesus macaques Immunogenetics 2010 [PMID: 20640416]
  36. Zanotto C, Pozzi E, Pacchioni S, Volonté L, Morghen CD, Radaelli A. Canarypox and fowlpox viruses as recombinant vaccine vectors: a biological and immunological comparison Antiviral research 2010 [PMID: 20643163]
  37. Koff WC, Berkley SF. The Renaissance in HIV Vaccine Development -- Future Directions The New England journal of medicine 2010 [PMID: 20647186]
  38. Willyard C. Tiny steps towards an HIV vaccine Nature 466(7304):S8 2010 [PMID: 20631706]
  39. Levy V, Evans JL, Stein ES, Davidson PJ, Lum PJ, Hahn JA, Page K. Are young injection drug users ready and willing to participate in preventive HCV vaccine trials? Vaccine 2010 [PMID: 20638453]
  40. French MA, Tanaskovic S, Law MG, Lim A, Fernandez S, Ward LD, Kelleher AD, Emery S. Vaccine-induced IgG2 anti-HIV p24 is associated with control of HIV in patients with a 'high-affinity' FcgammaRIIa genotype AIDS (London, England) 2010 [PMID: 20634666]
  41. Fox J, Castro H, Kaye S, McClure M, Weber JN, Fidler S. Epidemiology of non-B clade forms of HIV-1 in men who have sex with men in the UK AIDS (London, England) 2010 [PMID: 20634664]
  42. Powell RL, Kinge T, Nyambi PN. Infection by discordant strains of HIV-1 markedly enhances the neutralizing antibody response against heterologous virus Journal of virology 2010 [PMID: 20631143]
  43. Dieltjens T, Willems B, Coppens S, Van Nieuwenhove L, Humbert M, Dietrich U, Heyndrickx L, Vanham G, Janssens W. Unravelling the antigenic landscape of the HIV-1 subtype A envelope of an individual with broad cross-neutralizing antibodies using phage display peptide libraries Journal of virological methods 2010 [PMID: 20637241]
  44. Migueles SA, Connors M. Long-term nonprogressive disease among untreated HIV-infected individuals: clinical implications of understanding immune control of HIV JAMA : the journal of the American Medical Association 304(2):194-201 2010 [PMID: 20628133]
  45. Howell-Jones R, Bailey A, Beddows S, Sargent A, de Silva N, Wilson G, Anton J, Nichols T, Soldan K, Kitchener H. Multi-site study of HPV type-specific prevalence in women with cervical cancer, intraepithelial neoplasia and normal cytology, in England British journal of cancer 103(2):209-216 2010 [PMID: 20628396]
  46. Yang JD, Roberts LR. Hepatocellular carcinoma: a global view Nature reviews. Gastroenterology & hepatology 2010 [PMID: 20628345]
  47. Fraietta JA, Mueller YM, Do DH, Holmes VM, Howett MK, Lewis MG, Boesteanu AC, Alkan SS, Katsikis PD. Phosphorothioate 2' deoxyribose oligomers as microbicides that inhibit human immunodeficiency virus type 1 (HIV-1) infection and block Toll-like receptor (TLR)7/9-triggering by HIV-1 Antimicrobial agents and chemotherapy 2010 [PMID: 20625151]
  48. Bogojeska J, Bickel S, Altmann A, Lengauer T. Dealing with sparse data in predicting outcomes of HIV combination therapies Bioinformatics (Oxford, England) 2010 [PMID: 20624779]
  49. Belanger JM, Raviv Y, Viard M, Jason de la Cruz M, Nagashima K, Blumenthal R. Characterization of the Effects of Aryl-azido Compounds and UVA Irradiation on the Viral Proteins and Infectivity of Human Immunodeficiency Virus Type 1 Photochemistry and photobiology 2010 [PMID: 20630026]
  50. Jiang X, Burke V, Totrov M, Williams C, Cardozo T, Gorny MK, Zolla-Pazner S, Kong XP. Conserved structural elements in the V3 crown of HIV-1 gp120 Nature structural & molecular biology 2010 [PMID: 20622876]
  51. Fritz S, Mossdorf E, Durovic B, Zenhaeusern G, Conen A, Steffen I, Battegay M, Nüesch R, Hess C. Virosomal influenza-vaccine induced immunity in HIV-infected individuals with high versus low CD4+ T-cell counts: clues towards a rational vaccination strategy AIDS (London, England) 2010 [PMID: 20625265]
  52. Salmon-Céron D, Durier C, Desaint C, Cuzin L, Surenaud M, Hamouda NB, Lelièvre JD, Bonnet B, Pialoux G, Poizot-Martin I, Aboulker JP, Lévy Y, Launay O. Immunogenicity and safety of an HIV-1 lipopeptide vaccine in healthy adults: a phase 2 placebo-controlled ANRS trial AIDS (London, England) 2010 [PMID: 20625264]
  53. Lackman-Smith CS, Snyder BA, Marotte KM, Osterling MC, Mankowski MK, Jones M, Nieves-Duran L, Richardson-Harman N, Cummins JE Jr, Sanders-Beer BE. Safety and anti-HIV assessments of natural vaginal cleansing products in an established topical microbicides in vitro testing algorithm AIDS research and therapy 7(1):22 2010 [PMID: 20618951]
  54. Trono D, Van Lint C, Rouzioux C, Verdin E, Barré-Sinoussi F, Chun TW, Chomont N. HIV persistence and the prospect of long-term drug-free remissions for HIV-infected individuals Science (New York, N.Y.) 329(5988):174-180 2010 [PMID: 20616270]
  55. Cohen J. HIV/AIDS investigators few and far between Science (New York, N.Y.) 329(5988):173 2010 [PMID: 20616269]
  56. Kourtis AP, Ellington S, Bansil P, Jamieson DJ, Posner SF. Hospitalizations for Invasive Pneumococcal Disease Among HIV-1-Infected Adolescents and Adults in the United States in the Era of Highly Active Antiretroviral Therapy and the Conjugate Pneumococcal Vaccine Journal of acquired immune deficiency syndromes (1999) 2010 [PMID: 20622675]
  57. Wu X, Yang ZY, Li Y, Hogerkorp CM, Schief WR, Seaman MS, Zhou T, Schmidt SD, Wu L, Xu L, Longo NS, McKee K, O'Dell S, Louder MK, Wycuff DL, Feng Y, Nason M, Doria-Rose N, Connors M, Kwong PD, Roederer M, Wyatt RT, Nabel GJ, Mascola JR. Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1 Science (New York, N.Y.) 2010 [PMID: 20616233]
  58. Zhou T, Georgiev I, Wu X, Yang ZY, Dai K, Finzi A, Do Kwon Y, Scheid J, Shi W, Xu L, Yang Y, Zhu J, Nussenzweig MC, Sodroski J, Shapiro L, Nabel GJ, Mascola JR, Kwong PD. Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01 Science (New York, N.Y.) 2010 [PMID: 20616231]
  59. Tebas P, Frank I, Lewis M, Quinn J, Zifchak L, Thomas A, Kenney T, Kappes R, Wagner W, Maffei K, Sullivan K. Poor immunogenicity of the H1N1 2009 vaccine in well controlled HIV-infected individuals AIDS (London, England) 2010 [PMID: 20616698]
  60. Sundling C, O'Dell S, Douagi I, Forsell MN, Mörner A, Loré K, Mascola JR, Wyatt RT, Karlsson Hedestam GB. Immunization with wild-type or CD4 binding-defective HIV-1 Env trimers reduces viremia equivalently following heterologous SHIV challenge Journal of virology 2010 [PMID: 20610729]
  61. Knox KS, Vinton C, Hage CA, Kohli LM, Twigg HL 3rd, Klatt NR, Zwickl B, Waltz J, Goldman M, Douek DC, Brenchley JM. Reconstitution of CD4 T cells in BAL after Initiation of Highly Active Antiretroviral Therapy Journal of virology 2010 [PMID: 20610726]
  62. Almeida CA, Roberts SG, Laird R, McKinnon E, Ahmad I, Keane NM, Chopra A, Kadie C, Heckerman D, Mallal S, John M. Exploiting knowledge of immune selection in HIV-1 to detect HIV-specific CD8 T-cell responses Vaccine 2010 [PMID: 20619380]
  63. Lundqvist A, Fernandez-Rodrigues J, Ahlman K, Lagergård T. Detoxified Haemophilus ducreyi cytolethal distending toxin and induction of toxin specific antibodies in the genital tract Vaccine 2010 [PMID: 20609397]
  64. Dembek CJ, Kutscher S, Heltai S, Allgayer S, Biswas P, Ghezzi S, Vicenzi E, Hoffmann D, Reitmeir P, Tambussi G, Bogner JR, Lusso P, Stellbrink HJ, Santagostino E, Vollbrecht T, Goebel FD, Protzer U, Draenert R, Tinelli M, Poli G, Erfle V, Malnati M, Cosma A. Nef-specific CD45RA+ CD8+ T cells secreting MIP-1beta but not IFN-gamma are associated with nonprogressive HIV-1 infection AIDS research and therapy 7:20 2010 [PMID: 20598119]
  65. Du L, Zhao G, Zhang X, Liu Z, Yu H, Zheng BJ, Zhou Y, Jiang S. Development of a safe and convenient neutralization assay for rapid screening of influenza HA-specific neutralizing monoclonal antibodies Biochemical and biophysical research communications 397(3):580-585 2010 [PMID: 20617558]
  66. Tarosso LF, Sauer MM, Sanabani S, Giret MT, Tomiyama HI, Sidney J, Piaskowski SM, Diaz RS, Sabino EC, Sette A, Kalil-Filho J, Watkins DI, Kallas EG. Unexpected diversity of cellular immune responses against Nef and Vif in HIV-1-infected patients who spontaneously control viral replication PloS one 5(7):e11436 2010 [PMID: 20625436]
  67. Todd CS, Nasir A, Stanekzai MR, Bautista CT, Botros BA, Scott PT, Strathdee SA, Tjaden J. HIV, hepatitis B, and hepatitis C prevalence and associated risk behaviors among female sex workers in three Afghan cities AIDS (London, England) 24 Suppl 2:S69-75 2010 [PMID: 20610952]
  68. Psevdos G, Kim JH, Groce V, Sharp V. Efficacy of double-dose hepatitis B rescue vaccination in HIV-infected patients AIDS patient care and STDs 24(7):403-407 2010 [PMID: 20586648]
  69. Vázquez-Valls E, Escoto-Delgadillo M, López-Márquez FC, Castillero-Manzano M, Echegaray-Guerrero E, Bitzer-Quintero OK, Kobayashi-Gutiérrez A, Torres-Mendoza BM. Molecular epidemiology of HIV type 1 in Mexico: emergence of BG and BF intersubtype recombinants AIDS research and human retroviruses 26(7):777-781 2010 [PMID: 20624071]
  70. Qi Z, Pan C, Lu H, Shui Y, Li L, Li X, Xu X, Liu S, Jiang S. A recombinant mimetics of the HIV-1 gp41 prehairpin fusion intermediate fused with human IgG Fc fragment elicits neutralizing antibody response in the vaccinated mice Biochemical and biophysical research communications 2010 [PMID: 20599765]
  71. . HIV vaccine study approved Expert review of vaccines 9(7):693 2010 [PMID: 20624040]
  72. Garner EI. A case study: lessons learned from human papillomavirus vaccine development: approval of a vaccine for use in children and young adolescents for prevention of an adult disease Journal of acquired immune deficiency syndromes (1999) 54 Suppl 1:S50-52 2010 [PMID: 20571424]
  73. Rudy BJ, Kapogiannis BG, Lally MA, Gray GE, Bekker LG, Krogstad P, McGowan I. Youth-specific considerations in the development of preexposure prophylaxis, microbicide, and vaccine research trials Journal of acquired immune deficiency syndromes (1999) 54 Suppl 1:S31-42 2010 [PMID: 20571421]
  74. Nelson RM, Lewis LL, Struble K, Wood SF. Ethical and regulatory considerations for the inclusion of adolescents in HIV biomedical prevention research Journal of acquired immune deficiency syndromes (1999) 54 Suppl 1:S18-24 2010 [PMID: 20571419]
  75. Cagigi A, Nilsson A, Pensieroso S, Chiodi F. Dysfunctional B-cell responses during HIV-1 infection: implication for influenza vaccination and highly active antiretroviral therapy The Lancet infectious diseases 10(7):499-503 2010 [PMID: 20610332]
  76. Adoga MP, Gyar SD, Pechulano S, Bashayi OD, Emiasegen SE, Zungwe T, Iperepolu OH, Agupugo C, Agwale SM. Hepatitis B virus infections in apparently healthy urban Nigerians: data from pre-vaccination tests Journal of infection in developing countries 4(6):397-400 2010 [PMID: 20601793]
  77. Reynolds MR, Weiler AM, Piaskowski SM, Kolar HL, Hessell AJ, Weiker M, Weisgrau KL, León EJ, Rogers WE, Makowsky R, McDermott AB, Boyle R, Wilson NA, Allison DB, Burton DR, Koff WC, Watkins DI. Macaques Vaccinated with SIVmac239{Delta}nef Delay Acquisition and Control Replication after Repeated Low Dose Heterologous SIV Challenge Journal of virology 2010 [PMID: 20592091]
  78. Nájera JL, Gómez CE, García-Arriaza J, Sorzano CO, Esteban M. Insertion of vaccinia virus C7L host range gene into NYVAC-B genome potentiates immune responses against HIV-1 antigens PloS one 5(6):e11406 2010 [PMID: 20613977]
  79. Puthanakit T, Aurpibul L, Yoksan S, Sirisanthana T, Sirisanthana V. A 3-year follow-up of antibody response in HIV-infected children with immune recovery vaccinated with inactivated Japanese encephalitis vaccine Vaccine 2010 [PMID: 20600498]
  80. Saunders KO, Freel SA, Overman RG, Cunningham CK, Tomaras GD. Epigenetic regulation of CD8(+) T-lymphocyte mediated suppression of HIV-1 replication Virology 2010 [PMID: 20594570]
  81. Caron M, Besson G, Etenna SL, Mintsa-Ndong A, Mourtas S, Radaelli A, Morghen CD, Loddo R, La Colla P, Antimisiaris SG, Kazanji M. Protective properties of non-nucleoside reverse transcriptase inhibitor (MC1220) incorporated into liposome against intravaginal challenge of Rhesus Macaques with RT-SHIV Virology 2010 [PMID: 20591460]
  82. Vandermeulen C, Verhoye L, Vaidya S, Clement F, Brown KE, Hoppenbrouwers K, Leroux-Roels G. Detection of mumps virus-specific memory B cells by transfer of peripheral blood mononuclear cells into immune-deficient mice Immunology 2010 [PMID: 20586811]
  83. Curlin ME, Huang ML, Lu X, Celum CL, Sanchez J, Selke S, Baeten JM, Zuckerman RA, Erdman DD, Corey L. Frequent detection of human adenovirus from the lower gastrointestinal tract in men who have sex with men PloS one 5(6):e11321 2010 [PMID: 20593015]
  84. Ahlers JD, Belyakov IM. New paradigms for generating effective CD8+ T cell responses against HIV-1/AIDS Discovery medicine 9(49):528-537 2010 [PMID: 20587342]
  85. Pini A, Tomasoni LR, Cristini G, Puoti M, Matteelli A, Carosi G, Castelli F. Hepatitis A in men having sex with men (MSMs) in northern Italy Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive 18(2):113-114 2010 [PMID: 20610934]
  86. . Delaying the immune-suppressive function of regulatory T cells might enhance immune responses against HIV vaccines Immunotherapy 2(3):301 2010 [PMID: 20658753]
  87. Mitra AK, Rodriguez-Fernandez G. Latin America and the Caribbean: assessment of the advances in public health for the achievement of the Millennium Development Goals International journal of environmental research and public health 7(5):2238-2255 2010 [PMID: 20623022]
  88. Utzinger J, Bergquist R, Olveda R, Zhou XN. Important helminth infections in Southeast Asia diversity, potential for control and prospects for elimination Advances in parasitology 72:1-30 2010 [PMID: 20624526]
  89. Abdool Karim SS. HIV vaccine and microbicide trials turn a corner. We still don't have an effective vaccine or microbicide for the clinic, but two major trials this year brought us closer than we've ever been AIDS clinical care 22(1):2 2010 [PMID: 20617574]
  90. McCausland MM, Benhnia MR, Crickard L, Laudenslager J, Granger SW, Tahara T, Kubo R, Koriazova L, Kato S, Crotty S. Combination therapy of vaccinia virus infection with human anti-H3 and anti-B5 monoclonal antibodies in a small animal model Antiviral therapy 15(4):661-675 2010 [PMID: 20587859]
  91. Cirulli ET, Singh A, Shianna KV, Ge D, Smith JP, Maia JM, Heinzen EL, Goedert JJ, Goldstein DB. Screening the human exome: a comparison of whole genome and whole transcriptome sequencing Genome biology 11(5):R57 2010 [PMID: 20598109]
  92. Khrustalev VV. Levels of HIV1 gp120 3D B-cell Epitopes Mutability and Variability: Searching for Possible Vaccine Epitopes Immunological investigations 39(6):551-569 2010 [PMID: 20653424]
  93. Power C, Marfleet TW, Qualtiere L, Xiao W, Bretscher P. Development of Th1 imprints to rBCG expressing a foreign protein: implications for vaccination against HIV-1 and diverse influenza strains Journal of biomedicine & biotechnology 2010:591348 2010 [PMID: 20625498]
  94. Joseph J, Fernández-Lloris R, Pezzat E, Saubi N, Cardona PJ, Mothe B, Gatell JM. Molecular characterization of heterologous HIV-1gp120 gene expression disruption in mycobacterium bovis BCG host strain: a critical issue for engineering mycobacterial based-vaccine vectors Journal of biomedicine & biotechnology 2010:357370 2010 [PMID: 20617151]
  95. Azodo CC, Ehigiator O, Ojo MA. Occupational risks and hepatitis B vaccination status of dental auxiliaries in Nigeria Medical principles and practice : international journal of the Kuwait University, Health Science Centre 19(5):364-366 2010 [PMID: 20639659]
  96. Chaisson RE, Harrington M. How research can help control tuberculosis World hospitals and health services : the official journal of the International Hospital Federation 46(1):33-40 2010 [PMID: 20614683]
  97. Oshiro TM, de Almeida A, da Silva Duarte AJ. Dendritic cell immunotherapy for HIV infection: from theory to reality Immunotherapy 1(6):1039-1051 2009 [PMID: 20635918]
  98. Pashov A, Garimalla S, Monzavi-Karbassi B, Kieber-Emmons T. Carbohydrate targets in HIV vaccine research: lessons from failures Immunotherapy 1(5):777-794 2009 [PMID: 20636023]

Marburg virus

  1. Geisbert TW, Bausch DG, Feldmann H. Prospects for immunisation against Marburg and Ebola viruses Reviews in medical virology 2010 [PMID: 20658513]
  2. Geisbert T, Bailey M, Geisbert J, Asiedu C, Roederer M, Grazia-Pau M, Custers J, Jahrling P, Goudsmit J, Koup R, Sullivan NJ. Vector Choice Determines Immunogenicity and Potency of Genetic Vaccines Against Angola Marburgvirus in Nonhuman Primates Journal of virology 2010 [PMID: 20660192]
  3. Geisbert TW, Hensley LE, Geisbert JB, Leung A, Johnson JC, Grolla A, Feldmann H. Postexposure treatment of Marburg virus infection Emerging infectious diseases 16(7):1119-1122 2010 [PMID: 20587184]

Mycobacterium tuberculosis (tuberculosis)

  1. Gallant CJ, Cobat A, Simkin L, Black GF, Stanley K, Hughes J, Doherty TM, Hanekom WA, Eley B, Beyers N, Jaïs JP, van Helden P, Abel L, Alcaïs A, Hoal EG, Schurr E. Impact of age and sex on mycobacterial immunity in an area of high tuberculosis incidence The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 14(8):952-959 2010 [PMID: 20626938]
  2. Duplantis BN, Osusky M, Schmerk CL, Ross DR, Bosio CM, Nano FE. Essential genes from Arctic bacteria used to construct stable, temperature-sensitive bacterial vaccines Proceedings of the National Academy of Sciences of the United States of America 2010 [PMID: 20624965]
  3. Orme IM. The Achilles heel of BCG Tuberculosis (Edinburgh, Scotland) 2010 [PMID: 20659816]
  4. Russell DG, VanderVen BC, Lee W, Abramovitch RB, Kim MJ, Homolka S, Niemann S, Rohde KH. Mycobacterium tuberculosis wears what it eats Cell host & microbe 8(1):68-76 2010 [PMID: 20638643]
  5. Ho P, Wei X, Seah GT. Regulatory T cells induced by Mycobacterium chelonae sensitization influence murine responses to bacille Calmette-Guerin Journal of leukocyte biology 2010 [PMID: 20651297]
  6. Verhagen LM, Warris A, van Soolingen D, de Groot R, Hermans PW. Human Immunodeficiency Virus and Tuberculosis Coinfection in Children: Challenges in Diagnosis and Treatment The Pediatric infectious disease journal 2010 [PMID: 20651637]
  7. Burl S, Adetifa UJ, Cox M, Touray E, Ota MO, Marchant A, Whittle H, McShane H, Rowland-Jones SL, Flanagan KL. Delaying Bacillus Calmette-Guerin Vaccination from Birth to 4 1/2 Months of Age Reduces Postvaccination Th1 and IL-17 Responses but Leads to Comparable Mycobacterial Responses at 9 Months of Age Journal of immunology (Baltimore, Md. : 1950) 2010 [PMID: 20644160]
  8. Kirschner DE, Young D, Flynn JL. Tuberculosis: global approaches to a global disease Current opinion in biotechnology 2010 [PMID: 20637596]
  9. Cubillos-Ruiz A, Sandoval A, Ritacco V, López B, Robledo J, Correa N, Hernandez-Neuta I, Zambrano MM, Del Portillo P. Genomic Signatures of the Haarlem Lineage of Mycobacterium tuberculosis: Implications of Strain Genetic Variation in Drug and Vaccine Development Journal of clinical microbiology 2010 [PMID: 20631099]
  10. Corner LA, Costello E, O'Meara D, Lesellier S, Aldwell FE, Singh M, Hewinson RG, Chambers MA, Gormley E. Oral vaccination of badgers (Meles meles) with BCG and protective immunity against endobronchial challenge with Mycobacterium bovis Vaccine 2010 [PMID: 20637774]
  11. Cruz A, Fraga AG, Fountain JJ, Rangel-Moreno J, Torrado E, Saraiva M, Pereira DR, Randall TD, Pedrosa J, Cooper AM, Castro AG. Pathological role of interleukin 17 in mice subjected to repeated BCG vaccination after infection with Mycobacterium tuberculosis The Journal of experimental medicine 2010 [PMID: 20624887]
  12. Kumar V, Saravanan P, Arvind A, Mohan CG. Identification of hotspot regions of MurB oxidoreductase enzyme using homology modeling, molecular dynamics and molecular docking techniques Journal of molecular modeling 2010 [PMID: 20614148]
  13. Smith SG, Lalor MK, Gorak-Stolinska P, Blitz R, Beveridge NE, Worth A, McShane H, Dockrell HM. Mycobacterium tuberculosis PPD-induced immune biomarkers measurable in vitro following BCG vaccination of UK adolescents by multiplex bead array and intracellular cytokine staining BMC immunology 11:35 2010 [PMID: 20609237]
  14. Jin L, Wang G, Zhao X, Wang Z, Yang L, Yu A, Xu Y, Li W. Characterization and immune effect of the hepatitis B-BCG combined vaccine for using a needle innoculation Vaccine 2010 [PMID: 20619374]
  15. Connor LM, Harvie MC, Rich FJ, Quinn KM, Brinkmann V, Gros GL, Kirman JR. A key role for lung-resident memory lymphocytes in protective immune responses after BCG vaccination European journal of immunology 2010 [PMID: 20602436]
  16. Giri PK, Kruh NA, Dobos KM, Schorey JS. Proteomic analysis identifies highly antigenic proteins in exosomes from M. tuberculosis-infected and culture filtrate protein-treated macrophages Proteomics 2010 [PMID: 20662102]
  17. Whelan AO, Clifford D, Upadhyay B, Breadon EL, McNair J, Hewinson GR, Vordermeier MH. Development of a DIVA Skin-Test for Bovine Tuberculosis Journal of clinical microbiology 2010 [PMID: 20592155]
  18. Guthmann JP, Fonteneau L, Desplanques L, Lévy-Bruhl D. [BCG vaccination coverage in children born after the end of compulsory BCG vaccination and followed in maternal and child health clinics in France: A national survey 2009.] Archives de pediatrie : organe officiel de la Societe francaise de pediatrie 2010 [PMID: 20591630]
  19. Ahlers JD, Belyakov IM. New paradigms for generating effective CD8+ T cell responses against HIV-1/AIDS Discovery medicine 9(49):528-537 2010 [PMID: 20587342]
  20. Utzinger J, Bergquist R, Olveda R, Zhou XN. Important helminth infections in Southeast Asia diversity, potential for control and prospects for elimination Advances in parasitology 72:1-30 2010 [PMID: 20624526]
  21. Kiros TG, Power CA, Wei G, Bretscher PA. Immunization of newborn and adult mice with low numbers of BCG leads to Th1 responses, Th1 imprints and enhanced protection upon BCG challenge Immunotherapy 2(1):25-35 2010 [PMID: 20635889]
  22. Lucchese G, Stufano A, Kanduc D. Proposing low-similarity peptide vaccines against Mycobacterium tuberculosis Journal of biomedicine & biotechnology 2010:832341 2010 [PMID: 20625421]
  23. Davila J, Zhang L, Marrs CF, Durmaz R, Yang Z. Assessment of the genetic diversity of Mycobacterium tuberculosis esxA, esxH, and fbpB genes among clinical isolates and its implication for the future immunization by new tuberculosis subunit vaccines Ag85B-ESAT-6 and Ag85B-TB10.4 Journal of biomedicine & biotechnology 2010:208371 2010 [PMID: 20617139]
  24. Chaisson RE, Harrington M. How research can help control tuberculosis World hospitals and health services : the official journal of the International Hospital Federation 46(1):33-40 2010 [PMID: 20614683]
  25. Di Pentima C. Burden of non-sexually transmitted infections on adolescent growth and development in the developing world Adolescent medicine: state of the art reviews 20(3):930-948, x 2009 [PMID: 20653210]

Nipah virus

  1. Rockx B, Bossart KN, Feldmann F, Geisbert JB, Hickey AC, Brining D, Callison J, Safronetz D, Marzi A, Kercher L, Long D, Broder CC, Feldmann H, Geisbert TW. A novel model of lethal Hendra virus infection in African green monkeys and the effectiveness of ribavirin treatment Journal of virology 2010 [PMID: 20660198]
  2. Nahar N, Sultana R, Gurley ES, Hossain MJ, Luby SP. Date Palm Sap Collection: Exploring Opportunities to Prevent Nipah Transmission EcoHealth 2010 [PMID: 20617362]

Plasmodium falciparum (Malaria)

  1. Stanisic DI, Mueller I, Betuela I, Siba P, Schofield L. Robert Koch redux: malaria immunology in Papua New Guinea Parasite immunology 32(8):623-632 2010 [PMID: 20626817]
  2. Redmond AM, Doolan DL. The Australasian contribution to malaria vaccine development Parasite immunology 32(8):607-622 2010 [PMID: 20626816]
  3. Peacock C. Host and parasite genomics, an Australasian perspective Parasite immunology 32(8):599-606 2010 [PMID: 20626815]
  4. Boyle MJ, Wilson DW, Richards JS, Riglar DT, Tetteh KK, Conway DJ, Ralph SA, Baum J, Beeson JG. Isolation of viable Plasmodium falciparum merozoites to define erythrocyte invasion events and advance vaccine and drug development Proceedings of the National Academy of Sciences of the United States of America 2010 [PMID: 20660744]
  5. Engwerda CR, Good MF. A novel pathway of haematopoiesis revealed after experimental malaria infection Immunology and cell biology 2010 [PMID: 20644560]
  6. Arévalo-Pinzón G, Curtidor H, Vanegas M, Vizcaíno C, Patarroyo MA, Patarroyo ME. Conserved high-activity binding peptides from the Plasmodium falciparum Pf34 rhoptry protein inhibit merozoites in vitro invasion of red blood cells Peptides 2010 [PMID: 20654670]
  7. Li X, Fujio M, Imamura M, Wu D, Vasan S, Wong CH, Ho DD, Tsuji M. Design of a potent CD1d-binding NKT cell ligand as a vaccine adjuvant Proceedings of the National Academy of Sciences of the United States of America 107(29):13010-13015 2010 [PMID: 20616071]
  8. Gentil F, Bargieri DY, Leite JA, Françoso KS, Patricio MB, Espíndola NM, Vaz AJ, Palatnik-de-Sousa CB, Rodrigues MM, Costa FT, Soares IS. A recombinant vaccine based on domain II of Plasmodium vivax Apical Membrane Antigen 1 induces high antibody titres in mice Vaccine 2010 [PMID: 20654667]
  9. Mittra P, Singh N, Sharma YD. Plasmodium vivax: Immunological properties of tryptophan rich antigens PvTRAg 35.2 and PvTRAg 80.6 Microbes and infection / Institut Pasteur 2010 [PMID: 20638483]
  10. Schmidt NW, Butler NS, Badovinac VP, Harty JT. Extreme CD8 T Cell Requirements for Anti-Malarial Liver-Stage Immunity following Immunization with Radiation Attenuated Sporozoites PLoS pathogens 6(7):e1000998 2010 [PMID: 20657824]
  11. Findlay EG, Greig R, Stumhofer JS, Hafalla JC, de Souza JB, Saris CJ, Hunter CA, Riley EM, Couper KN. Essential Role for IL-27 Receptor Signaling in Prevention of Th1-Mediated Immunopathology during Malaria Infection Journal of immunology (Baltimore, Md. : 1950) 2010 [PMID: 20631310]
  12. Pinzon-Charry A, McPhun V, Kienzle V, Hirunpetcharat C, Engwerda C, McCarthy J, Good MF. Low doses of killed parasite in CpG elicit vigorous CD4+ T cell responses against blood-stage malaria in mice The Journal of clinical investigation 2010 [PMID: 20628205]
  13. Du C, Nilsson S, Lu H, Yin J, Jiang N, Wahlgren M, Chen Q. Immunogenicity of the Plasmodium falciparum Pf332-DBL domain in combination with different adjuvants Vaccine 28(31):4977-4983 2010 [PMID: 20653104]
  14. McCall MB, Sauerwein RW. Interferon-{gamma}--central mediator of protective immune responses against the pre-erythrocytic and blood stage of malaria Journal of leukocyte biology 2010 [PMID: 20610802]
  15. Pham NL, Pewe LL, Fleenor CJ, Langlois RA, Legge KL, Badovinac VP, Harty JT. Exploiting cross-priming to generate protective CD8 T-cell immunity rapidly Proceedings of the National Academy of Sciences of the United States of America 107(27):12198-12203 2010 [PMID: 20616089]
  16. Coban C, Horii T, Akira S, Ishii KJ. TLR9 and endogenous adjuvants of the whole blood-stage malaria vaccine Expert review of vaccines 9(7):775-784 2010 [PMID: 20624050]
  17. Cruz-Chan JV, Rosado-Vallado M, Dumonteil E. Malaria vaccine efficacy: overcoming the helminth hurdle Expert review of vaccines 9(7):707-711 2010 [PMID: 20624043]
  18. Kar S, Kar S. Control of malaria Nature reviews. Drug discovery 9(7):511-512 2010 [PMID: 20592740]
  19. Dare JT, Kouri DP, Zimmerman PA, Thomas PJ. Differentiating Plasmodium falciparum alleles by transforming Cartesian X,Y data to polar coordinates BMC genetics 11(1):57 2010 [PMID: 20587031]
  20. Lança AS, de Sousa KP, Atouguia J, Prazeres DM, Monteiro GA, Silva MS. Trypanosoma brucei: Immunisation with plasmid DNA encoding invariant surface glycoprotein gene is able to induce partial protection in experimental African trypanosomiasis Experimental parasitology 2010 [PMID: 20599996]
  21. Jones P, Leder K, Woolley I, Cameron P, Cheng A, Spelman D. Postsplenectomy infection - strategies for prevention in general practice Australian family physician 39(6):383-386 2010 [PMID: 20628676]
  22. Ahlers JD, Belyakov IM. New paradigms for generating effective CD8+ T cell responses against HIV-1/AIDS Discovery medicine 9(49):528-537 2010 [PMID: 20587342]
  23. Mitra AK, Rodriguez-Fernandez G. Latin America and the Caribbean: assessment of the advances in public health for the achievement of the Millennium Development Goals International journal of environmental research and public health 7(5):2238-2255 2010 [PMID: 20623022]
  24. Sirima SB, Tiono AB, Ouédraogo A, Diarra A, Ouédraogo AL, Yaro JB, Ouédraogo E, Gansané A, Bougouma EC, Konaté AT, Kaboré Y, Traoré A, Roma C, Soulama I, Luty AJ, Druilhe P, Cousens S, Nébié I. Correction: Safety and Immunogenicity of the Malaria Vaccine Candidate MSP3 Long Synthetic Peptide in 12-24 Months-Old Burkinabe Children PloS one 5(4) 2010 [PMID: 20657640]
  25. . New Malaria vaccine proves promising in Mali children Human vaccines 6(3) 2010 [PMID: 20595813]
  26. Buckee CO, Gupta S. Modelling malaria population structure and its implications for control Advances in experimental medicine and biology 673:112-126 2010 [PMID: 20632533]
  27. Utzinger J, Bergquist R, Olveda R, Zhou XN. Important helminth infections in Southeast Asia diversity, potential for control and prospects for elimination Advances in parasitology 72:1-30 2010 [PMID: 20624526]
  28. Di Pentima C. Burden of non-sexually transmitted infections on adolescent growth and development in the developing world Adolescent medicine: state of the art reviews 20(3):930-948, x 2009 [PMID: 20653210]

Salmonella

  1. Duplantis BN, Osusky M, Schmerk CL, Ross DR, Bosio CM, Nano FE. Essential genes from Arctic bacteria used to construct stable, temperature-sensitive bacterial vaccines Proceedings of the National Academy of Sciences of the United States of America 2010 [PMID: 20624965]
  2. Salerno-Goncalves R, Wahid R, Sztein MB. Ex vivo Kinetics of Early and Long-Term Multifunctional HLA-E specific CD8+ Cells in Volunteers Immunized with Ty21a Typhoid Vaccine Clinical and vaccine immunology : CVI 2010 [PMID: 20660136]
  3. Meltzer E, Schwartz E. Enteric fever: a travel medicine oriented view Current opinion in infectious diseases 2010 [PMID: 20613510]
  4. Salam MA, Katz J, Michalek SM. Role of Toll-like receptors in host responses to a virulence antigen of Streptococcus mutans expressed by a recombinant, attenuated Salmonella vector vaccine Vaccine 28(31):4928-4936 2010 [PMID: 20653102]
  5. Luby SP, Halder AK, Saha SK, Naheed A, Sazzad HM, Akhter S, Gurley ES, Brooks WA, El-Arifeen S, Najnin N, Nazneen A, Breiman RF. A low-cost approach to measure the burden of vaccine preventable diseases in urban areas Vaccine 28(31):4903-4912 2010 [PMID: 20653079]
  6. Torres-Escobar A, Juárez-Rodríguez MD, Branger CG, Curtiss R 3rd. Evaluation of the humoral immune response in mice orally vaccinated with live recombinant attenuated Salmonella enterica delivering a secreted form of Yersinia pestis PsaA Vaccine 2010 [PMID: 20600475]
  7. Pietilä TE, Latvala S, Osterlund P, Julkunen I. Inhibition of dynamin-dependent endocytosis interferes with type III IFN expression in bacteria-infected human monocyte-derived DCs Journal of leukocyte biology 2010 [PMID: 20610797]
  8. Khare S, Alali W, Zhang S, Hunter D, Pugh R, Fang FC, Libby SJ, Adams LG. Vaccination with attenuated Salmonella enterica Dublin expressing E. coli O157:H7 outer membrane protein Intimin induces transient reduction of fecal shedding of E. coli O157:H7 in cattle BMC veterinary research 6(1):35 2010 [PMID: 20609252]
  9. Wang S, Li Y, Scarpellini G, Kong W, Shi H, Baek CH, Gunn B, Wanda SY, Roland KL, Zhang X, Senechal-Willis P, Curtiss R 3rd. Salmonella vaccine vectors displaying delayed antigen synthesis in vivo to enhance immunogenicity Infection and immunity 2010 [PMID: 20605977]
  10. Kong Q, Liu Q, Jansen AM, Curtiss R 3rd. Regulated delayed expression of rfc enhances the immunogenicity and protective efficacy of a heterologous antigen delivered by live attenuated Salmonella enterica vaccines Vaccine 2010 [PMID: 20599580]
  11. Podda A, Saul AJ, Arora R, Bhutta Z, Sinha A, Gaind R, Singhal T, Saha S, Brooks A, Martin LB, Amdekar Y, Chitkara AJ, Shieh M, Kapur AN, Chugh TD. Conjugate vaccines for enteric fever: proceedings of a meeting organized in New Delhi, India in 2009 Journal of infection in developing countries 4(6):404-411 2010 [PMID: 20601795]
  12. Desin TS, Mickael CS, Lam PK, Potter AA, Köster W. Protection of epithelial cells from Salmonella enterica serovar Enteritidis invasion by antibodies against the SPI-1 type III secretion system Canadian journal of microbiology 56(6):522-526 2010 [PMID: 20657623]
  13. Richards SM, Strandberg KL, Gunn JS. Salmonella-regulated lipopolysaccharide modifications Sub-cellular biochemistry 53:101-122 2010 [PMID: 20593264]

Shigella

  1. Tribble D, Kaminski R, Cantrell J, Nelson M, Porter C, Baqar S, Williams C, Arora R, Saunders J, Ananthakrishnan M, Sanders J, Zaucha G, Turbyfill R, Oaks E. Safety and immunogenicity of a Shigella flexneri 2a Invaplex 50 intranasal vaccine in adult volunteers Vaccine 2010 [PMID: 20619378]

Variola major (Smallpox)

  1. Huemer HP, Lassnig C, Nowotny N, Irschick EU, Kitchen M, Pavlic M. Diazepam leads to enhanced severity of orthopoxvirus infection and immune suppression Vaccine 2010 [PMID: 20659521]
  2. Buchman GW, Cohen ME, Xiao Y, Richardson-Harman N, Silvera P, Detolla LJ, Davis HL, Eisenberg RJ, Cohen GH, Isaacs SN. A protein-based smallpox vaccine protects non-human primates from a lethal monkeypox virus challenge Vaccine 2010 [PMID: 20659519]
  3. Davis NA, Crowe JE Jr, Pajewski NM, McKinney BA. Surfing a genetic association interaction network to identify modulators of antibody response to smallpox vaccine Genes and immunity 2010 [PMID: 20613780]
  4. . Vaccinia virus infection after sexual contact with a military smallpox vaccinee -Washington, 2010 MMWR. Morbidity and mortality weekly report 59(25):773-775 2010 [PMID: 20592687]
  5. Jang HC, Kim CJ, Kim KH, Lee KH, Byun YH, Seong BL, Saletti G, Czerkinsky C, Park WB, Park SW, Kim HB, Kim NJ, Oh MD. A randomized, double-blind, controlled clinical trial to evaluate the efficacy and safety of CJ-50300, a newly developed cell culture-derived smallpox vaccine, in healthy volunteers Vaccine 2010 [PMID: 20600480]
  6. Conti AA. The parallel evolution of immunology and pharmacology International journal of immunopathology and pharmacology 23(2):655-657 2010 [PMID: 20646363]
  7. McCausland MM, Benhnia MR, Crickard L, Laudenslager J, Granger SW, Tahara T, Kubo R, Koriazova L, Kato S, Crotty S. Combination therapy of vaccinia virus infection with human anti-H3 and anti-B5 monoclonal antibodies in a small animal model Antiviral therapy 15(4):661-675 2010 [PMID: 20587859]

Venezuelan equine encephalitis virus

  1. Hu WG, Phelps AL, Jager S, Chau D, Hu CC, O'Brien LM, Perkins SD, Gates AJ, Phillpotts RJ, Nagata LP. A recombinant humanized monoclonal antibody completely protects mice against lethal challenge with Venezuelan equine encephalitis virus Vaccine 28(34):5558-5564 2010 [PMID: 20600509]

Yersinia pestis (Plague)

  1. Soliakov A, Harris JR, Watkinson A, Lakey JH. The structure of Yersinia pestis Caf1 polymer in free and adjuvant bound states Vaccine 28(35):5746-5754 2010 [PMID: 20600492]
  2. Musson JA, Ingram R, Durand G, Ascough S, Waters EL, Hartley MG, Robson T, Maillere B, Williamson ED, Sriskandan S, Altmann D, Robinson JH. Repertoire of HLA-DR1-restricted CD4 T cell responses to capsular Caf1 antigen of Y. pestis HLA-transgenic mice Infection and immunity 2010 [PMID: 20660611]
  3. Rosales-Mendoza S, Soria-Guerra RE, Moreno-Fierros L, Han Y, Alpuche-Solís AG, Korban SS. Transgenic carrot tap roots expressing an immunogenic F1-V fusion protein from Yersinia pestis are immunogenic in mice Journal of plant physiology 2010 [PMID: 20655621]
  4. Brewoo JN, Powell TD, Stinchcomb DT, Osorio JE. Efficacy and safety of a modified vaccinia Ankara (MVA) vectored plague vaccine in mice Vaccine 2010 [PMID: 20638759]
  5. Torres-Escobar A, Juárez-Rodríguez MD, Branger CG, Curtiss R 3rd. Evaluation of the humoral immune response in mice orally vaccinated with live recombinant attenuated Salmonella enterica delivering a secreted form of Yersinia pestis PsaA Vaccine 2010 [PMID: 20600475]
  6. Blanchette CD, Fischer NO, Corzett M, Bench G, Hoeprich PD. Kinetic Analysis of His-Tagged Protein Binding to Nickel-Chelating Nanolipoprotein Particles Bioconjugate chemistry 2010 [PMID: 20586461]
  7. Jones A, Bosio C, Duffy A, Goodyear A, Schriefer M, Dow S. Protection against pneumonic plague following oral immunization with a non-replicating vaccine Vaccine 2010 [PMID: 20600517]

Click HERE to see the publications in the last month.